Picard Medical Faces Securities Lawsuit Over Alleged Stock Promotion Scheme

Reuters
02/19
Picard Medical Faces Securities Lawsuit Over Alleged Stock Promotion Scheme

Picard Medical Inc. is facing a securities class action lawsuit alleging the company and certain defendants made materially false or misleading statements between Sept. 2, 2025 and Oct. 31, 2025. The complaint claims the stock was inflated by a fraudulent social media-driven promotion scheme and coordinated share dumping through offshore or nominee accounts, and that the company’s disclosures failed to address the alleged misinformation and artificial trading activity. An April 3, 2026 deadline has been set for shareholders to seek appointment as lead plaintiff.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Picard Medical Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202602181705PRIMZONEFULLFEED9657177) on February 18, 2026, and is solely responsible for the information contained therein.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10